Prognostication in brain tumors.

Area of Science:

• Neuro-oncology
• Palliative Care
• Medical Ethics

Background:

• Brain tumors, particularly glial tumors like glioblastoma multiforme and anaplastic glioma, have a poor prognosis despite aggressive treatments.
• Palliative care needs differ significantly between primary and secondary brain tumors due to disease trajectory and prognosis variations.
• Effective communication of prognosis and treatment goals is vital for respecting patient autonomy and facilitating shared decision-making.

Purpose of the Study:

• To analyze the complex factors influencing communication and treatment decisions in primary brain tumor patients.
• To highlight the unique trajectory of brain tumors, especially during the end-of-life phase, compared to the general cancer population.
• To identify barriers to effective prognosis communication and explore strategies for improved patient involvement in care.

Main Methods:

• Review of neuro-oncological literature on communication, prognosis awareness, and decision-making in brain tumor patients.
• Analysis of the impact of cognitive deficits on Medical Decisions Capacity (MDC) and patient participation.
• Examination of patients' coping styles and their influence on communication and care planning.

Main Results:

• Cognitive deficits in brain tumor patients significantly impair their capacity to understand, reason, and express choices, impacting their Medical Decisions Capacity.
• Patients' coping styles influence communication regarding diagnosis, prognosis, treatment goals, and end-of-life care preferences.
• Several barriers impede effective communication, hindering patients' involvement in treatment decisions, particularly in palliative care.

Conclusions:

• Improving prognostic awareness and communication is essential for respecting brain tumor patient autonomy and preferences.
• Addressing cognitive deficits and understanding coping styles are critical for enhancing communication quality.
• Developing effective strategies to overcome communication barriers is necessary to promote patient involvement in treatment and end-of-life decision-making.